{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:04:47Z","timestamp":1789380287404,"version":"build-2803163510"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CCHTS"],"published-print":{"date-parts":[[2026,9,10]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Esophageal Squamous Cell Carcinoma (ESCC) is a highly aggressive malignancy\nwith limited therapeutic options and poor prognosis, particularly in advanced stages. Dingxiang\nGuan Shitong Decoction (DGD) is a traditional Chinese medicine preparation that can alleviate symptoms\nin patients with advanced ESCC. However, the chemical composition, pharmacological effects,\nand molecular mechanisms of action of DGD remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This study evaluated the efficacy of DGD in advanced ESCC by conducting a clinical trial.\nUltra-Performance Liquid Chromatography-Mass Spectrometry (UPLC-MS) was employed to identify\nthe chemical constituents of DGD. The interaction between the bioactive compounds in DGD and potential\ntargets of ESCC was predicted using network pharmacology analysis, and the predictions were\nverified by molecular docking. The effects of DGD on cell biology and the expression of predicted target\ngenes were confirmed in vitro using the ESCC cell line.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>DGD treatment significantly improved quality of life and TCM syndrome scores in patients with\nadvanced ESCC. The UPLC-MS analysis identified 54 bioactive components in DGD. Network pharmacological\nanalysis indicated that these bioactive components in DGD could target 129 potential ESCC-related\ngenes. Functional analysis demonstrated that these core target genes were enriched in tumor-related pathways,\nincluding the p53 signaling pathway, apoptosis, and the IL-17 signaling pathway. Molecular docking\nexperiments showed that the core DGD constituents (quercetin, kaempferol, and \u03b2-sitosterol) exhibited\nstrong binding affinities for the protein products of key target genes (such as TP53 and AKT1). Moreover,\nin vitro experiments demonstrated that DGD inhibited the proliferation and migration of Eca-109 cells and\nsimultaneously induced apoptosis in a dose-dependent manner. In addition, DGD treatment upregulated the\nexpression of Bax, cleaved caspase-3, and p53 at the protein level in Eca-109 cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>The integration of clinical observation, metabolomics, network prediction, and experimental\nvalidation provides a multi-level understanding of DGD's therapeutic mechanism. The convergence of computational\npredictions and in vitro experimental data strongly supports the p53\/caspase-3 axis as a key mediator\nof DGD-induced apoptosis. These findings position DGD as a promising adjunctive therapy for advanced\nESCC, particularly for patients who are ineligible for or intolerant of aggressive conventional treatments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Our study provides evidence that DGD leads to significant improvements in the quality of life\nfor individuals diagnosed with advanced ESCC. Its active ingredients may exert anti-tumor effects by inducing\napoptosis through the p53\/caspase-3 signaling pathway. This study provides foundational data for\nthe clinical application of DGD and a basis for further investigation of its pharmacological mechanism.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113862073483593260903044354","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:22:43Z","timestamp":1789377763000},"source":"Crossref","is-referenced-by-count":0,"title":["Integrated Metabolomics, Network Pharmacology, and Experimental Validation Elucidate the Mechanisms Underlying Dingxiang-Guanshitong Decoction in the Treatment of Esophageal Squamous Cell Carcinoma"],"prefix":"10.2174","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2285-5640","authenticated-orcid":true,"given":"Yaling","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Oncology, the First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450000,Henan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6648-3311","authenticated-orcid":true,"given":"Dongdong","family":"Li","sequence":"additional","affiliation":[{"name":"Henan Provincial Hospital of TCM, Zhengzhou 450000, Henan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8851-7797","authenticated-orcid":true,"given":"Tianqing","family":"Sang","sequence":"additional","affiliation":[{"name":"Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210008, Jiangsu Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5005-6833","authenticated-orcid":true,"given":"Yajing","family":"Yang","sequence":"additional","affiliation":[{"name":"Henan University of Chinese Medicine, Zhengzhou 450000, Henan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1587-0746","authenticated-orcid":true,"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Henan Cancer Hospital, Zhengzhou 450000, Henan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3755-8454","authenticated-orcid":true,"given":"Tao","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Oncology, the First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450000,Henan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7522-8091","authenticated-orcid":true,"given":"Xiaoqi","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Oncology, the First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450000,Henan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0402-5518","authenticated-orcid":true,"given":"Yuling","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Oncology, the First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450000,Henan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2278-2993","authenticated-orcid":true,"given":"Suhui","family":"Wu","sequence":"additional","affiliation":[{"name":"Henan University of Chinese Medicine, Zhengzhou 450000, Henan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Combinatorial Chemistry &amp; High Throughput Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113862073483593260903044354","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/258210\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113862073483593260903044354","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:22:44Z","timestamp":1789377764000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/258210\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113862073483593260903044354","relation":{},"ISSN":["1386-2073"],"issn-type":[{"value":"1386-2073","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,10]]}}}